On Wednesday, February 4, 2015, the Scientific Liaison Coalition (SLC) hosted a webinar, “Prediction is Very Difficult, Especially if it is About the Future: How Well Does Toxicology Testing Predict Clinical Outcomes?” presented by Thomas W. Jones, Chief Scientific Officer, Toxicology and Pathology, Eli Lilly and Company. An overview of this webinar was presented in a recent blog posting.
Over 700 individuals engaged in this webinar that addressed the debate around the future of nonclinical safety testing. This presentation by Dr. Jones considered a quantitative framework with which nonclinical safety model performance can be assessed, highlighted the data needed to enable such an approach, and discussed the implications of new model and technology applications in R&D. SLC 2014–2015 Chair Mary Jeanne Kallman hosted the webinar and immediate Past Chair Kevin McDorman served as the moderator.
Scientists from around the globe participated in this webinar, including attendees from Belgium, Brazil, Canada, China, Denmark, France, Germany, India, Italy, Spain, Switzerland, Taiwan, United Kingdom, and United States.
This webinar is a demonstration of the SLC mission of “improving the ability of societies to partner with other domestic and international organizations that have objectives consistent with the goal of increasing the impact of the science of toxicology to improve public health."
You can access the webinar recording on the SLC website. For additional information about the SLC, please visit the SLC website and/or contact Marcia Lawson.